New Clinical Data from Phase 2 Trial of LUT014 for the Treatment of Patients With EGFRI-Induced Acneiform Rash Accepted for Oral Presentation at the Clinical Trials Plenary Session TEL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback